RxDoctor Payments Data

Jill Harrison, MD

Psychiatry · Plymouth, MANPI 1518192293

Payments from drug & device makers

$1,074in general payments, 2019–2025

Across 57 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$151
  • Otsuka America Pharmaceutical, Inc.$143
  • Neurocrine Biosciences, Inc.$143
  • Alkermes, Inc.$112
  • Johnson & Johnson$103
  • AbbVie$102
  • plus $320 from 7 others

What the payments were for

  • Food & beverage$96189%
  • Education$11311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,074 in reported general payments places this provider in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$11,595
Medicare patients
13
Services billed
104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide54$30,186
RexultiBrexpiprazole17$24,050
SuboxoneBuprenorphine Hcl/Naloxone Hcl34$19,269
SeroquelQuetiapine Fumarate12$12,537
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl45$5,883
Aripiprazole98$2,335
Clonazepam348$2,268
Asenapine Maleate12$1,680
Trazodone Hcl145$1,407
Mirtazapine114$1,133
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine48$1,119
Sertraline Hcl121$1,108
Lurasidone Hcl54$1,069
Gabapentin80$952
Duloxetine Hcl55$815

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$89$30,18654 claims
Otsuka America Pharmaceutical, Inc.Rexulti$143$24,05017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Plymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →